These findings in human SLE and murine lupus models support our hypothesis that increased TNF expression in Sh3bp2 gain-of-function mutant cells might ameliorate clinical and immunological phenotypes observed in lupus-prone mice. The gene discussed is TNF; the disease is systemic lupus erythematosus.